Company profile: Atomic Alchemy
1.1 - Company Overview
Company description
- Provider of radioisotopes for medical, research, exploration, and industrial use, aiming to establish a reliable domestic supply in the U.S. for medical radioisotopes such as molybdenum-99, in a market that currently lacks a dedicated domestic supplier and relies on university research reactors.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Atomic Alchemy
Cryoniss
HQ: United Kingdom
Website
- Description: Provider of temperature-controlled biobanking and cold-chain logistics for life sciences, offering regulated storage of human biological samples at vapour phase liquid nitrogen, -80°C, -20°C, +4°C and ambient; cell banking and culture with next-day dispatch; bioreagents storage with cloud-based traceability; cell line QC testing via preferred suppliers; end-to-end sample transport; and access to samples for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoniss company profile →
Microbia
HQ: United States
Website
- Description: Provider of industrial biotechnology, developing, producing, and commercializing fermentation-based specialty ingredients and biomaterials, including carotenoids, biopolymers, and other biomaterials; maintains a strategic alliance with Tate & Lyle Investments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbia company profile →
BAC
HQ: United States
Website
- Description: Provider of affinity purification products and services for the biopharmaceutical market, with CaptureSelect products used from drug discovery to manufacturing of biopharmaceuticals, based on a proprietary platform integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BAC company profile →
Zedira
HQ: Germany
Website
- Description: Provider of transglutaminase-focused biotech solutions, including specialty reagents for R&D and diagnostics; small-molecule drug candidates such as ZED1227 for celiac disease; fee-for-service transglutaminase activity measurement; recombinant microbial transglutaminase (Andracon) for ADC production; diagnostic antigens (TG2, TG3, TG6, DGPs); and an Anti-TG6 ELISA kit.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zedira company profile →
Hemanext
HQ: United States
Website
- Description: Provider of blood processing, storage, and transfusion solutions. Offers Hemanext ONE, a blood container set for processing and storing red blood cells under reduced oxygen and carbon dioxide conditions to improve quality and extend shelf-life.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemanext company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Atomic Alchemy
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Atomic Alchemy
2.2 - Growth funds investing in similar companies to Atomic Alchemy
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Atomic Alchemy
4.2 - Public trading comparable groups for Atomic Alchemy
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →